Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Dooradoyle – page 2

40 clinical trials in Dooradoyle, Ireland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dooradoyle at a glance
40
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

40 trials in Dooradoyle

Open in trial search

Cystic fibrosis

Recruiting

Study on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Deutivacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Gilead Sciences Inc.

Epcoritamab plus rituximab versus rituximab alone in elderly, frail or unfit patients with newly diagnosed diffuse large B‑cell lymphoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:65+ years
  • Substances:Epcoritamab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study on Erythromycin and Neomycin for Preventing Infections After Colorectal Surgery in Patients Undergoing Elective Procedures

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Erythromycin
  • Sponsor:University Hospital Limerick

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Acasunlimab
  • Sponsor:Genmab A/S

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Acute myeloid leukaemia+1

Not recruiting

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Breast cancer+7

Not recruiting

Study of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH

Breast cancer

Not recruiting

Study on the Effects of Chemotherapy and Endocrine Therapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer Using Tamoxifen and Anastrozole

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Cancer Trials Ireland

Plasma cell myeloma

Not recruiting

Study on the Effectiveness and Safety of Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Cancer Trials Ireland

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:pharmaand GmbH

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Dooradoyle

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on chronic lymphocytic leukemia (CLL) treatment approaches, comparing the effectiveness of different therapeutic combinations including ibrutinib monotherapy versus combination treatments with venetoclax and obinutuzumab.

  • Treatment-naive CLL patients
  • Progression-free survival assessment
  • Novel therapy combinations

This research aims to establish optimal treatment protocols for previously untreated CLL patients.

02 Prostate Cancer Research

Groundbreaking studies in metastatic prostate cancer treatment, evaluating the effectiveness of ADT combined with darolutamide in patients with specific clinical characteristics.

  • Castration-naïve metastatic disease
  • Radiographic progression monitoring
  • Targeted therapy approaches

Focused on improving outcomes for vulnerable patients with newly diagnosed metastatic disease.

03 Advanced Prostate Cancer Therapeutics

Investigation of combination therapies for metastatic castration-resistant prostate cancer (mCRPC), examining the potential benefits of combining pembrolizumab with enzalutamide.

  • Overall survival assessment
  • Radiographic progression tracking
  • Immunotherapy combinations

Evaluating innovative treatment strategies to improve outcomes in resistant disease states.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.